Trade Mark Journal No.2026/009 27 February 2026

WO0000001901847 (5,42,44)

Office of origin: United States of America

Date of International Registration:16 January 2026
Date of designation in the UK: 16 January 2026
Image for mark 1901847 RASONQUE

International priority date claimed: 5 September 2025 (United States of America) (99377590)
Class 5
Pharmaceutical preparations for the treatment of oncological and immune system related diseases and disorders.
Class 42
Pharmaceutical research and development; drug discovery services; providing information about medical and scientific research.
Class 44
Providing medical information; providing health information.

Revolution Medicines, Inc.

Representative: Melissa A. Nowak Christensen O'Connor Johnson Kindness, 1201 Third Avenue,, Suite 3600, Seattle WA 98101, UNITED STATES OF AMERICA